These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3219688)

  • 21. Third Belgian multicentre survey of antibiotic susceptibility of anaerobic bacteria.
    Wybo I; Piérard D; Verschraegen I; Reynders M; Vandoorslaer K; Claeys G; Delmée M; Glupczynski Y; Gordts B; Ieven M; Melin P; Struelens M; Verhaegen J; Lauwers S
    J Antimicrob Chemother; 2007 Jan; 59(1):132-9. PubMed ID: 17095529
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Sensitivity of strict anaerobic bacteria to metronidazole, cefoxitin, and clindamycin].
    Dubreuil L; Derriennic M; Reynaud A; Devos J; Romond C; Courtieu A
    Pathol Biol (Paris); 1985 Nov; 33(9):899-903. PubMed ID: 3909082
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimicrobial susceptibility of anaerobic and aerobic bacteria isolated from patients with mixed infections in Nicaragua.
    Cáceres M; Carrera E; Palma A; Berrios G; Weintraub A; Nord CE
    Rev Esp Quimioter; 1999 Dec; 12(4):332-9. PubMed ID: 10855012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparative study in vitro on the activity of 7 antibiotics against anaerobic bacteria from hospital isolates].
    Braga A; Bernieri F; Mandelli M; Mosconi P; Rossi A
    Boll Ist Sieroter Milan; 1985; 64(4):294-301. PubMed ID: 4074510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro activity of imipenem against gram-positive anaerobic bacteria.
    Dubreuil L; Devos J; Romond C
    Int J Clin Pharmacol Res; 1987; 7(1):39-43. PubMed ID: 3473047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anaerobic bacteria isolated from foot infections in diabetic patients: in vitro susceptibility to nine antibiotics.
    Ginunas VJ; Canawati HN; Sapico FL
    Clin Ther; 1984; 6(4):457-60. PubMed ID: 6467279
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of in vivo and in vitro efficacy of ceftizoxime.
    Delaney ML; Cisneros RL; Onderdonk AB
    Clin Ther; 1990; 12 Suppl C():25-30. PubMed ID: 2390772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of spiral gradient and conventional agar dilution for susceptibility testing of anaerobic bacteria.
    Wexler HM; Molitoris E; Jashnian F; Finegold SM
    Antimicrob Agents Chemother; 1991 Jun; 35(6):1196-202. PubMed ID: 1929262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reevaluation of Enterobacteriaceae MIC/disk diffusion zone diameter regression scattergrams for 9 beta-lactams: adjustments of breakpoints for strains producing extended spectrum beta-lactamases.
    Jones RN; Craig WA; Ambrose PG; Dudley MN; Pottumarthy S
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):235-46. PubMed ID: 16105568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of three broth disk methods for testing the susceptibility of anaerobic bacteria to imipenem.
    Shungu DL; Weinberg E; Cerami AT
    J Clin Microbiol; 1985 Jun; 21(6):875-9. PubMed ID: 3859487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of susceptibilities of anaerobic bacteria determined by agar dilution and by a microbroth method.
    Baron EJ; Bruckner DA
    Rev Infect Dis; 1984; 6 Suppl 1():S249-53. PubMed ID: 6718938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the Etest for susceptibility testing of anaerobic bacteria.
    Rosenblatt JE; Gustafson DR
    Diagn Microbiol Infect Dis; 1995 Jul; 22(3):279-84. PubMed ID: 8565417
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modified agar dilution method for rapid antibiotic susceptibility testing of anaerobic bacteria.
    Hanson CW; Martin WJ
    Antimicrob Agents Chemother; 1978 Mar; 13(3):383-8. PubMed ID: 400819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microbroth versus agar dilution for susceptibility testing of fluoroquinolones and other agents against anaerobic bacteria.
    Krepel CJ; Gohr CM; Edmiston CE; Condon RE
    J Antimicrob Chemother; 1993 Oct; 32(4):571-5. PubMed ID: 8288498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Susceptibility of anaerobic bacteria to ALP 201.
    Nord CE; Lindmark A; Persson I
    Antimicrob Agents Chemother; 1989 Dec; 33(12):2137-9. PubMed ID: 2619278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of two broth disk methods for antibiotic susceptibility testing of anaerobes.
    Helstad AG; Hutchinson MA; Amos WP; Kurzynski TA
    Antimicrob Agents Chemother; 1984 Oct; 26(4):601-3. PubMed ID: 6517551
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the E test for susceptibility testing of anaerobic bacteria.
    Citron DM; Ostovari MI; Karlsson A; Goldstein EJ
    J Clin Microbiol; 1991 Oct; 29(10):2197-203. PubMed ID: 1939571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the 10-micrograms clindamycin disk for susceptibility testing of anaerobes by the aerobically incubated thioglycolate broth disk method.
    Toohey KL; Kurzynski TA; Schell RF; Birk RJ; Zabransky RJ
    J Clin Microbiol; 1986 Mar; 23(3):619-21. PubMed ID: 3958150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quality control guidelines for testing cefotetan in the reference agar dilution procedure for susceptibility testing of anaerobic bacteria.
    Zabransky RJ; Bobey DG; Barry AL; Allen SD; Fuchs PC; Gerlach EH; Thornsberry C; Sheikh W; Jones RN
    J Clin Microbiol; 1989 Jan; 27(1):190-1. PubMed ID: 2643621
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of spiral gradient endpoint and agar dilution methods for susceptibility testing of anaerobic bacteria: a multilaboratory collaborative evaluation.
    Wexler HM; Molitoris E; Murray PR; Washington J; Zabransky RJ; Edelstein PH; Finegold SM
    J Clin Microbiol; 1996 Jan; 34(1):170-4. PubMed ID: 8748295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.